| Apollo Endosurgery is a holding company. Through its subsidiaries, Co. is a medical technology company primarily focused on the design, development and commercialization of medical devices to develop gastrointestinal (GI) therapeutic endoscopy. Co.'s products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat various GI conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders (peroral endoscopic myotomy); esophageal stent fixation and obesity. We show 25 historical shares outstanding datapoints in our APEN shares outstanding history coverage, used to compute APEN market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing APEN market cap history over the course of time is important for investors
interested in comparing APEN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of APEN versus a peer is one thing; comparing
APEN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like APEN can fluctuate over the course of history.
With this page we aim to empower investors researching APEN by allowing them to research the APEN market cap history.